Nifty
Sensex
:
:
9837.40
31524.68
-66.75 (-0.67%)
-270.78 (-0.85%)

Chemicals

Rating :
69/99

BSE: 500201 | NSE: INDIAGLYCO

165.70
-3.85 (-2.27%)
18-Aug-2017 | 3:55PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 168.65
  • 168.65
  • 164.50
  • 169.55
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  • 36930
  • 61.19
  • 208.90
  • 94.25

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 511.64
  • 11.37
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,577.39
  • 0.61%
  • 0.60

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 61.07%
  • 6.03%
  • 29.07%
  • FII
  • DII
  • Others
  • 0.09%
  • 1.89%
  • 1.85%

Chart

Price | P:E | P:BV | EV:EBITDA

Quarterly Results

Standalone Figures in Rs. Crores

Description
Mar 17
Mar 16
Var%
Dec 16
Dec 15
Var%
Sep 16
Sep 15
Var%
Jun 16
Jun 15
Var%
Net Sales
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PBT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Net Sales
2,499.56
2,324.22
2,579.50
2,976.57
3,422.56
2,757.83
1,762.12
1,197.86
1,024.90
1,343.93
Net Sales Growth
7.54%
-9.90%
-13.34%
-13.03%
24.10%
56.51%
47.11%
16.88%
-23.74%
 
Cost Of Goods Sold
1,470.45
1,316.38
1,638.08
1,960.87
2,144.68
1,615.16
1,028.11
678.66
579.15
589.35
Gross Profit
1,029.11
1,007.84
941.41
1,015.70
1,277.89
1,142.67
734.01
519.20
445.75
754.59
GP Margin
41.17%
43.36%
36.50%
34.12%
37.34%
41.43%
41.65%
43.34%
43.49%
56.15%
Total Expenditure
2,263.30
2,146.43
2,455.63
2,774.85
3,069.89
2,468.04
1,580.34
1,122.96
1,027.27
1,036.63
Power & Fuel Cost
288.99
301.60
335.94
348.26
350.98
321.86
238.35
183.94
163.92
162.17
% Of Sales
11.56%
12.98%
13.02%
11.70%
10.25%
11.67%
13.53%
15.36%
15.99%
12.07%
Employee Cost
96.04
88.37
92.14
86.77
89.12
76.32
72.25
48.37
47.80
40.08
% Of Sales
3.84%
3.80%
3.57%
2.92%
2.60%
2.77%
4.10%
4.04%
4.66%
2.98%
Manufacturing Exp.
225.86
240.67
211.75
221.12
226.35
172.17
130.76
123.11
109.16
98.75
% Of Sales
9.04%
10.35%
8.21%
7.43%
6.61%
6.24%
7.42%
10.28%
10.65%
7.35%
General & Admin Exp.
91.36
95.84
61.46
62.09
55.96
50.31
46.24
24.93
27.56
52.91
% Of Sales
3.66%
4.12%
2.38%
2.09%
1.64%
1.82%
2.62%
2.08%
2.69%
3.94%
Selling & Distn. Exp.
86.16
89.72
90.51
74.49
98.54
79.17
54.98
47.06
40.23
44.75
% Of Sales
3.45%
3.86%
3.51%
2.50%
2.88%
2.87%
3.12%
3.93%
3.93%
3.33%
Miscellaneous Exp.
4.44
13.84
25.74
21.26
104.26
153.05
9.65
16.89
59.45
44.75
% Of Sales
0.18%
0.60%
1.00%
0.71%
3.05%
5.55%
0.55%
1.41%
5.80%
3.62%
EBITDA
236.26
177.79
123.87
201.72
352.67
289.79
181.78
74.90
-2.37
307.30
EBITDA Margin
9.45%
7.65%
4.80%
6.78%
10.30%
10.51%
10.32%
6.25%
-0.23%
22.87%
Other Income
14.04
16.97
57.59
27.49
48.46
66.71
9.95
72.65
49.12
49.22
Interest
133.13
145.54
178.67
158.50
171.34
151.49
119.12
80.12
91.37
50.75
Depreciation
72.04
69.48
88.78
90.61
90.18
85.32
76.42
66.58
62.35
68.10
PBT
45.14
-20.27
-86.01
-19.90
139.62
119.70
-3.81
0.85
-106.98
237.67
Tax
9.95
-24.36
-55.32
-50.27
44.09
52.29
11.14
11.10
-45.28
59.13
Tax Rate
22.04%
30.02%
38.42%
23.75%
31.58%
43.68%
-292.39%
64.84%
29.33%
24.88%
PAT
35.20
-56.78
-88.64
-161.36
95.53
67.41
-14.81
6.01
-109.08
178.54
PAT before Minority Interest
35.20
-56.78
-88.64
-161.36
95.53
67.41
-14.95
6.01
-109.08
178.54
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.14
0.00
0.00
0.00
PAT Margin
1.41%
-2.44%
-3.44%
-5.42%
2.79%
2.44%
-0.84%
0.50%
-10.64%
13.28%
PAT Growth
161.99%
35.94%
45.07%
-268.91%
41.71%
555.17%
-346.42%
105.51%
-161.10%
 
Unadjusted EPS
11.32
-18.35
-28.63
-52.12
32.46
24.18
-5.31
2.16
-39.12
64.03

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Shareholder's Funds
752.33
718.17
297.05
372.45
535.82
413.86
384.29
385.42
372.20
492.65
Share Capital
30.96
30.96
30.96
30.96
30.96
27.88
27.88
27.88
27.88
27.88
Total Reserves
721.37
687.21
266.09
341.49
504.85
385.98
356.41
357.54
344.32
464.76
Non-Current Liabilities
837.73
1,065.30
458.71
828.62
884.17
867.77
687.21
1,353.13
1,162.53
742.30
Secured Loans
59.05
180.91
395.44
640.19
636.15
595.96
581.51
1,270.78
965.02
601.11
Unsecured Loans
5.69
14.51
5.24
69.10
80.94
120.00
26.23
35.42
161.69
55.90
Long Term Provisions
5.97
5.61
5.20
4.04
3.21
33.16
16.12
0.00
0.00
0.00
Current Liabilities
1,902.19
1,836.03
2,399.04
2,083.32
1,770.36
1,835.15
1,344.28
332.39
251.36
222.61
Trade Payables
578.68
480.57
246.53
491.14
516.75
247.29
134.50
206.76
103.98
106.75
Other Current Liabilities
438.53
335.71
729.54
434.34
328.54
356.65
318.90
76.99
97.73
53.14
Short Term Borrowings
879.84
1,016.10
1,417.59
1,110.07
840.14
1,203.62
882.05
0.00
0.00
0.00
Short Term Provisions
5.14
3.65
5.38
47.76
84.93
27.59
8.83
48.64
49.66
62.73
Total Liabilities
3,492.25
3,619.50
3,154.80
3,284.39
3,190.35
3,116.78
2,415.78
2,071.08
1,786.25
1,458.28
Net Block
2,109.82
2,028.90
1,145.92
1,309.48
1,216.13
1,191.01
1,176.16
922.06
835.22
749.63
Gross Block
2,246.19
2,100.01
2,010.02
2,099.68
1,923.44
1,815.72
1,717.28
1,388.09
1,236.28
1,109.59
Accumulated Depreciation
136.37
71.11
864.09
790.20
707.32
624.71
541.12
466.03
401.05
359.96
Non Current Assets
2,357.95
2,339.48
1,370.65
1,510.90
1,488.32
1,497.03
1,415.91
1,295.23
1,222.01
912.20
Capital Work in Progress
91.36
181.17
161.87
137.43
201.88
104.85
128.94
371.29
384.90
160.69
Non Current Investment
26.24
27.74
4.00
4.04
1.88
1.89
1.88
1.88
1.88
1.88
Long Term Loans & Adv.
59.46
56.20
58.16
58.66
63.63
198.16
103.85
0.00
0.00
0.00
Other Non Current Assets
71.08
45.46
0.70
1.28
4.80
1.12
5.08
0.00
0.00
0.00
Current Assets
1,131.70
1,276.55
1,781.71
1,771.54
1,700.47
1,618.94
999.86
775.53
562.64
546.08
Current Investments
0.00
0.00
0.00
0.10
171.92
15.90
0.76
0.75
0.82
0.75
Inventories
518.04
515.65
487.09
586.75
570.79
699.32
501.44
427.86
266.69
270.29
Sundry Debtors
390.41
363.57
437.20
440.61
295.89
298.90
161.92
116.74
69.41
88.38
Cash & Bank
29.43
37.98
161.92
164.47
132.91
303.51
188.02
48.56
45.06
27.15
Other Current Assets
193.81
152.96
38.62
48.85
528.96
301.31
147.72
181.61
180.66
159.52
Short Term Loans & Adv.
92.87
206.38
656.89
530.76
454.42
211.19
109.13
156.22
168.17
148.32
Net Current Assets
-770.50
-559.49
-617.34
-311.78
-69.89
-216.20
-344.41
443.14
311.27
323.47
Total Assets
3,492.25
3,619.52
3,154.80
3,284.40
3,190.34
3,116.78
2,415.77
2,071.09
1,786.26
1,458.28

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Cash From Operating Activity
302.07
1,230.65
-171.03
-233.87
817.20
-23.67
-42.20
-17.19
3.43
144.08
PBT
45.14
-81.14
-143.96
-211.62
139.62
119.70
-3.81
17.12
-154.36
237.67
Adjustment
188.51
217.22
249.69
311.01
251.59
230.16
184.12
91.02
178.17
99.42
Changes in Working Capital
65.93
1,096.39
-274.19
-328.48
474.70
-355.85
-221.14
-146.14
-12.01
-143.06
Cash after chg. in Working capital
299.58
1,232.47
-168.46
-229.10
865.91
-6.00
-40.83
-38.00
11.80
194.03
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
2.49
-1.82
-2.57
-4.77
-48.71
-17.67
-1.36
20.81
-8.37
-49.95
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-40.12
-78.33
174.61
109.84
-227.07
-199.61
-69.48
-114.08
-320.05
-197.18
Net Fixed Assets
-56.38
-222.41
79.26
-103.48
-195.79
-107.66
-58.20
-116.97
-257.02
-134.35
Net Investments
1.49
53.41
-24.88
171.82
-156.52
-15.15
-16.01
-28.18
-0.07
-10.30
Others
14.77
90.67
120.23
41.50
125.24
-76.80
4.73
31.07
-62.96
-52.53
Cash from Financing Activity
-262.86
-1,167.60
-3.80
86.60
-582.03
239.98
251.14
134.69
334.41
56.92
Net Cash Inflow / Outflow
-0.92
-15.28
-0.22
-37.44
8.10
16.69
139.46
3.42
17.79
3.83
Opening Cash & Equivalents
6.41
21.69
22.08
59.77
51.76
35.22
48.56
45.06
27.15
13.47
Closing Cash & Equivalent
5.50
6.41
21.84
22.08
59.77
51.76
188.02
48.56
45.06
27.15

Financial Ratios

Consolidated /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Book Value (Rs.)
242.15
230.83
95.15
119.66
172.56
148.14
137.82
138.11
132.91
176.69
ROA
0.99%
-1.68%
-2.75%
-4.98%
3.03%
2.44%
-0.67%
0.31%
-6.72%
13.44%
ROE
4.81%
-11.25%
-26.66%
-35.67%
20.17%
16.91%
-3.89%
1.59%
-25.27%
44.10%
ROCE
9.39%
2.86%
1.39%
-2.25%
12.75%
11.67%
6.12%
6.10%
-4.76%
28.59%
Fixed Asset Turnover
1.66
1.59
1.53
1.76
2.11
1.78
1.29
1.10
1.04
1.56
Receivable days
38.12
44.60
50.84
37.88
27.47
26.77
25.44
23.62
23.69
19.27
Inventory Days
52.27
55.85
62.19
59.54
58.67
69.75
84.85
88.12
80.61
57.52
Payable days
86.57
62.17
55.66
66.53
46.11
29.10
35.75
42.16
37.95
54.41
Cash Conversion Cycle
3.82
38.28
57.37
30.90
40.03
67.42
74.55
69.57
66.35
22.39
Total Debt/Equity
1.46
1.73
7.69
5.54
3.31
5.23
4.40
3.39
3.04
1.33
Interest Cover
1.34
0.44
0.19
-0.34
1.81
1.79
0.97
1.21
-0.69
5.68

News Update


  • India Glycols reports net profit of Rs 15.85 crore for Q4FY17
    17th May 2017, 11:21 AM

    Total income from operations of the company increased by 11.17% at Rs 892.00 crore for quarter under review

    Read More
  • India Glycols - Quarterly Results
    16th May 2017, 12:00 AM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.